Green Cross Medical Science Corporation (142280) — Capital Reinvestment Ratio
Green Cross Medical Science Corporation (142280) has a Capital Reinvestment Ratio of 0.09x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩5.01 Billion) in capital expenditures (₩460.89 Million). See free cash flow generation of Green Cross Medical Science Corporation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Green Cross Medical Science Corporation Capital Reinvestment Ratio (2016–2025)
This chart tracks Green Cross Medical Science Corporation's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Green Cross Medical Science Corporation (2016–2025)
Year-by-year Capital Reinvestment Ratio for Green Cross Medical Science Corporation from 2016 to 2025. For live market cap and broader valuation context, see Green Cross Medical Science Corporation stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | ₩7.20 Billion | ₩4.90 Billion | ▼ -22.5% |
| 2024 | 0.88x | ₩3.66 Billion | ₩3.22 Billion | ▼ -33.9% |
| 2023 | 1.33x | ₩4.24 Billion | ₩5.63 Billion | ▲ +321.7% |
| 2022 | 0.31x | ₩10.88 Billion | ₩3.43 Billion | ▼ -11.4% |
| 2017 | 0.36x | ₩3.11 Billion | ₩1.11 Billion | ▲ +93.2% |
| 2016 | 0.18x | ₩10.25 Billion | ₩1.89 Billion | — |